NCT04712942 2023-08-21Treatment of MDS/AML Patients With an Impending Hematological Relapse With AZA or ATA and PevonedistatUniversity of LeipzigPhase 2 Completed14 enrolled
NCT02610777 2022-09-19An Efficacy and Safety Study of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine in Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML) and Low-Blast Acute Myelogenous Leukemia (AML)TakedaPhase 2 Completed120 enrolled 39 charts